x

Posted 13 January, 2023

AMEDISYS INC appointed new CEO

CEO Change detected for ticker Nasdaq:AMED in a 8-K filed on 13 January, 2023.


  On January 9, 2023, Amedisys, Inc. (the "Company") entered into a Separation Agreement and General Release (the "Separation Agreement") with Christopher T. Gerard, the Company's former President and Chief Executive Officer, in connection with the previously disclosed termination of Mr. Gerard without cause on November 17, 2022.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of AMEDISYS INC
Health Care/Life Sciences • Healthcare Provision
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.
Market Cap
$3.02B
View Company Details
AMEDISYS INC by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 

On January 9, 2023, Amedisys, Inc. (the "Company") entered into a Separation Agreement and General Release (the "Separation Agreement") with Christopher T. Gerard, the Company's former President and Chief Executive Officer, in connection with the previously disclosed termination of Mr. Gerard without cause on November 17, 2022. 

Pursuant to the Separation Agreement and in accordance with the Amedisys Holding, L.L.C. Severance Plan for the Chief Executive Officer, Mr. Gerard will be entitled to a cash payment of $4,050,000, equal to two times his annual base salary plus target bonus for the 2022 fiscal year (the "Severance Payment"). Under the terms of the Separation Agreement, which contains a release of claims against the Company, Mr. Gerard may revoke the Separation Agreement for a period of seven days after January 9, 2023, the date Mr. Gerard executed the Separation Agreement. The Separation Agreement will not become effective and enforceable until the seven-day revocation period has ended. The Severance Payment is subject to forfeiture and clawback if Mr. Gerard breaches any of the provisions of the Separation Agreement. 

Also on January 9, 2023, Mr. Gerard resigned from the Board of Directors of the Company, effective immediately. 

The above description of the terms of the Separation Agreement is not complete and is qualified by reference to the complete document, which will be filed by the Company with the Company's Quarterly Report on Form 10-Q for the quarter ending March 31, 2023.